-
Posted by
Two Blokes Jul 25 -
Filed in
Stock
-
3 views
Edwards Lifesciences' EW stock surged Friday following a strong second-quarter 2025 earnings report that saw the medical device innovator surpass revenue and earnings expectations, driven by significant growth across its heart valve therapies.
